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Abstract
Background: Human T-Lymphotropic Virus Type 1 (HTLV-1) infection causes lethal adult T-cell leukemia (ATL) and severely
debilitating HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in up to 5% of infected adults. HTLV-1 is
endemic in parts of Africa and the highest prevalence in West Africa (5%) has been reported in Caio, a rural area in the
North-West of Guinea-Bissau. It is not known which HTLV-1 variants are present in this community. Sequence data can
provide insights in the molecular epidemiology and help to understand the origin and spread of HTLV-1.
Objective: To gain insight into the molecular diversity of HTLV-1 in West Africa.
Methods: HTLV-1 infected individuals were identified in community surveys between 1990–2007. The complete Long
Terminal Repeat (LTR) and p24 coding region of HTLV-1 was sequenced from infected subjects. Socio-demographic data
were obtained from community census and from interviews performed by fieldworkers. Phylogenetic analyses were
performed to characterize the relationship between the Caio HTLV-1 and HTLV-1 from other parts of the world.
Results: LTR and p24 sequences were obtained from 72 individuals (36 LTR, 24 p24 only and 12 both). Consistent with the
low evolutionary change of HTLV-1, many of the sequences from unrelated individuals showed 100% nucleotide identity.
Most (45 of 46) of the LTR sequences clustered with the Cosmopolitan HTLV-1 subtype 1a, subgroup D (1aD). LTR and p24
sequences from two subjects were divergent and formed a significant cluster with HTLV-1 subtype 1g, and with the most
divergent African Simian T-cell Lymphotropic Virus, Tan90.
Conclusions: The Cosmopolitan HTLV-1 1aD predominates in this rural West African community. However, HTLV-1 subtype
1g is also present. This subtype has not been described before in West Africa and may be more widespread than previously
thought. These data are in line with the hypothesis that multiple monkey-to-man zoonotic events are contributing to HTLV-
1 diversity.
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Introduction
The retrovirus Human T-Lymphotropic Virus type 1 (HTLV-1)
was first discovered in 1979 [1]. Approximately 5% of HTLV-1
carriers develop Adult T-cell Leukemia (ATL) or HTLV-
associated myelopathy/tropical spastic paraparesis (HAM/TSP).
ATL (and other HTLV-1 associated diseases have been described
in West African individuals [2,3,4]. It is not known how many
people are infected worldwide [5], but the prevalence is high in
Japan, Africa, the Caribbean and South America (reviewed in [6]).
Transmission of HTLV-1 is vertical (mainly through prolonged
breastfeeding), sexual and via contaminated blood products
(reviewed in [6]). HTLV-1 infection is believed to have originated
in multiple zoonotic events from monkeys. Cross-species trans-
mission of HTLV-1 from monkey to men is probably ongoing and
still actively contributing to the endemic [7,8].
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HTLV-1 is an ancient retrovirus with a very low evolutionary
rate (especially compared to HIV) [9]. The Simian T-cell
Lymphotropic Virus and HTLV are together referred to as
Primate T-cell Lymphotropic Virus (PTLV). Currently, 7 different
HTLV-1 subtypes, based primarily on the nucleotide sequence of
the LTR region, have been described; the Cosmopolitan subtype
(1a) that has spread worldwide and is further divided into
subgroups (A–E), 4 African subtypes (1b, 1d, 1e, 1f) and a
Melanesian/Australian subtype (1c). In 2005 a new African
subtype g was described by Wolfe et al. based on sequence data
from two infected subjects [7]. The origins of HTLV-1 are
believed to be either in Asia or Africa and current data do not
provide clear support for one or the other continent. The most
divergent STLV-1 strain thus far identified is Asian (MarB43)
suggesting that MarB43 separated earlier from an ancestral virus
than the PTLV-1s found in Africa [10] and supporting a
hypothesis that the origin of PTLV-1 lies in Asia [10]. On the
other hand, only HTLV-1 subtype a has been found in Asia, while
all known HTLV-1 subtypes are present in Africa, providing
support for an African origin of HTLV-1 [11]. Additional samples
and phylogenetic data are needed to answer this question [12].
After an initial dispersion in Asia and Africa, the Cosmopolitan
subtype 1a spread worldwide and is thought to have been
introduced into the Americas during the post-Columbian slave
trade [13]. In people of African descent in South America, mainly
Cosmopolitan subtype 1a subgroup A is found [13]. In Africa,
subgroup A has been found primarily in Southern Africa while in
West Africa (the origin of a large proportion of the slaves that were
taken to South America) only subgroups C and D have been
identified so far [14]. This presents a puzzle - subgroup A is
common in South Americans of African decent yet uncommon (at
least based on the currently available sequence data) in the African
regions from which a large proportion of slaves were brought to
South America. Additional HTLV-1 sequence data from West
Africa are needed to resolve this enigma.
The study area of the current analysis is a rural community in
Guinea-Bissau and has the highest reported HTLV-1 prevalence
in West Africa (5% in 2007) [15], but no sequence data exist from
this area and the subtypes of HTLV-1 circulating in the area are
not yet identified. Also, the contribution of the various HTLV
transmission routes in this community is not well documented . To
examine the molecular epidemiology and to define the routes of
transmission of HTLV-1 in the Caio community in Guinea Bissau,
we characterized the HTLV-1 LTR and p24 region from a
collection of DNA samples isolated from children and adults from
this cohort. We describe highly conserved examples of HTLV-1
subtype d, most closely related to isolates reported from Bissau and
two examples of subtype g, which is the first time this subtype has
been reported in West Africa.
Methods
Ethics statement
Informed consent was obtained from all the study participants.
From 2003 onwards, written informed consent was obtained as
required by the Gambian Ethics Committee. In studies prior to the
2003 study, written informed consent was not required by the
Gambia Government/MRC MRC Laboratories Joint Ethics
Committee nor by the Ministry of Health of Guinea-Bissau and
thus verbal consent was obtained. The documentation of the
informed consent was done in a two-step process. After
information on the study was given by the field worker, and after
having responded to any questions that the prospective participant
might have, the field worker asked whether the participant was
willing to participate in the study. The field worker noted down
the answer by ticking one of two boxes (Accepting to participate in
study or not); a separate question was asked about providing a
blood sample and the answer to this question was noted
separately.. All studies, (both prior to and after 2003), were
approved by the Gambia Government/MRC MRC Laboratories
Joint Ethics Committee and by the Ministry of Health of Guinea-
Bissau.
Study population and samples
The study area, Caio, is a settlement of 10 small villages with
10,000 inhabitants in North-Western Guinea-Bissau and has been
described in detail [16]. A rolling census has been performed in
the area since 1988 as part of a research project on HIV-2 [17]. In
1990, 1997 and 2007, population surveys were conducted to study
the prevalence, incidence and risk factors of HIV-1, HIV-2, and
HTLV-1 infection and these surveys included approximately 75%
of the adult population [18]. A cohort was established to study the
natural history of HIV-2; included were all HIV-2 infected adults
and a similar number of controls, matched for age, sex, and
village. This cohort was established in 1991, and subjects were
examined in 1996, 2003, and 2006. In addition, in 2004 a cross-
sectional study was performed to examine mother-to-child
transmission of HTLV-1 [19]. HTLV-1 prevalence has been
stable at around 5% in Caio throughout this period [15].
In the studies conducted in 2003, 2006 and 2007, DNA was
extracted from blood samples (whole blood and peripheral blood
mononuclear cells), and stored for molecular analyses. Because
these samples have been used in different studies, not each HTLV-
1 infected individual had a stored sample; some samples had been
depleted during other studies or could not be traced or storage had
failed (e.g. freezer breakdowns). The available samples were used
for HTLV-1 sequencing for the current study.
Samples for LTR sequencing were selected in 2010 from stored
DNA samples. All complete LTR sequences obtained from
mother-child pairs from the vertical transmission study in 2004
were also used in the current analysis (accession numbers
JN655856 to JN655872). [19]. Samples for p24 sequencing were
randomly selected in 2009 from stored DNA samples for an as yet
unpublished immunological study.
Author Summary
Human T-Lymphotropic Virus type 1 (HTLV-1) affects
millions of people worldwide. It is very similar to Simian
T-Lymphotropic Virus, a virus that circulates in monkeys.
HTLV-1 causes a lethal form of leukemia (Adult T-cell
Leukemia) and a debilitating neurological syndrome
(HTLV-associated myelopathy/tropical spastic paraparesis)
in approximately 5% of infected people. Based on
sequence variation, HTLV-1 can be divided into 7 subtypes
(1a–1g) with the Cosmopolitan subtype 1a further subdi-
vided into subgroups (A–E). We examined HTLV-1 diversity
in a rural area in Guinea-Bissau, a country in West Africa
with a high HTLV-1 prevalence (5%). We found that most
viruses belong to the Cosmopolitan subtype 1a, subgroup
D, but 2 viruses belonged to subtype 1g. This subtype had
thus far only been found in monkey hunters in Cameroon,
who were probably recently infected by monkeys. Our
findings indicate that this subtype has spread beyond
Central Africa. An important, unresolved question is
whether persons with this subtype were infected by
monkeys or through human-to-human transmission.
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HTLV-1 diagnosis
In the 1997, 2003 and 2004 studies, plasma samples were tested
for the presence of antibodies to HTLV-1 and HTLV-2 using a
Murex HTLV-1+2 ELISA (Abbott Murex Diagnostics, Dartford,
UK). Reactive samples were retested by the same assay. HTLV-1
infection status was further determined by PCR using primers
targeted to the tax/rex gene [20]. Each PCR reaction also
included 10 copies of phage lambda DNA. This was co-amplified
with specific primers in the same reaction to control for non-
specific inhibition. Because the tax/rex primers amplified both
HTLV-1 and HTLV-2 sequences, the amplicons were digested
with the restriction enzyme Sau 3A (which cuts only HTLV-1) to
distinguish products from the two viruses. In this study all PCR-
positive samples were confirmed to be HTLV-1 by Sau 3A
digestion. The HTLV-1 testing in the 2007 study (2 ELISAs and
PCR confirmation) and the HIV testing of previous studies have
been described in detail [15].
HTLV-1 LTR and p24 PCR and sequencing
Amplification of the HTLV-1 proviral DNA was performed
with nested PCR. PCR primers were optimized for a melting
temperature (Tm) between 57 and 60uC and are listed in Table 1.
The complete LTR region was obtained by amplifying two
overlapping fragments similar to the strategy used by Salemi et al.
[21]. For each patient sample, a 438 bp 59 LTR-gag (primers
MO195-198) and a 475 bp tax-39LTR fragment (primers
MO199-202) were obtained. The p24 coding region was amplified
on an 840 bp fragment using the nested primers MO076-079.
PCR products were purified using Qiaquick Gel Extraction
(Qiagen) and sequenced using the inner PCR primers from both
directions by Macrogen (www.macrogen.com). Complete LTR
and p24 sequences were assembled and ambiguities were resolved
using the sequence alignment editor BioEdit. [22] All new
sequences generated here have been deposited in Genbank with
the following accession numbers (JQ583778 to JQ583845) (Table
S1).
Phylogenetic analysis
Multiple sequence alignments of the LTR and the related
sequences in the GenBank/EMBL database were performed with
the Clustal [23] and Dambe softwares [24]. A minimal editing of
the alignment was performed manually with GeneDoc [25].
Neighbor-joining (NJ) and maximum-likelihood (ML) phylogenetic
analyses were performed with PAUP*, version 4.0b10 [26]. The
Tamura-Nei evolutionary model (taking into account a different
substitution rate for transversions, purine and pyrimidine transi-
tions and allowing an intersite substitution rate heterogeneity
modelled with a gamma distribution) was chosen as best model
(alpha parameter of 0.6) using Modeltest 3.06 [27]. The NJ tree
was constructed with an optimized nucleotide substitution rate
matrix and gamma shape parameter using empirical base
frequencies. The reliability of the NJ trees was evaluated by
analyzing 1,000 bootstrap replicates and bootstrap values of
.60% were considered significant. For the ML tree reconstruction
a heuristic search with the subtree-pruning-regrafting branch
swapping algorithm was performed using the NJ tree as starting
tree including its optimised parameters. A likelihood ratio test was
used to calculate the statistical support for the branches (expressed
in p-values). Trees were drawn with TreeView 1.4 [28].
Results
Study subjects and sequences
HTLV-1 LTR and/or p24 sequences were obtained from 72
individuals (Table 2). In order to obtain LTR sequences from
persons who had been infected relatively recently (between 1997
and 2007) or earlier (prior to 1990 or 1997), samples were selected
from individuals diagnosed with HTLV-1 in 2007. Other samples
were randomly selected from the 2003 study. Of the 72 individuals
yielding sequence, 14 (19%) were diagnosed with HTLV-1 in
1990, 17 (24%) in 1997, 5 (7%) in 2003 and 28 (40%) in 2007
(Table S1). Twenty-five (35%) individuals were co-infected with
HIV; 1 was HIV-1, 19 were HIV-2 and 5 were HIV-1/HIV-2
dual co-infected. Eight (11%) sequences came from children, who
were all diagnosed with HTLV-1 in 2004 and who were all HIV
negative.
Information on relationships between individuals from whom
sequences were available was obtained from census data and
interviews; there was one married couple (Caio5846 & Caio5884),
2 siblings (Caio4757 & Caio4758) and 6 mother-child pairs
(Caio4634 & Caio4635; Caio4647 & Caio4650; Caio4658 &
Table 1. Primers used for HTLV-1 LTR and p24 PCR and
sequencing.
Primer Function Sequence (59 to 39) Comment
MO195 59LTR-gag OF AACTAGCAGGAGTCTATAAAAGCG based on AV117
MO196 59LTR-gag OR AAAGATTTGGCCCATTGCCTAG based on AV118
MO197 59LTR-gag IF ACAGTTCAGGAGGGGGCTC based on AV119
MO198 59LTR-gag IR TAGGGAATAAAGGGGCGCTC based on AV120
MO199 Tax-39 LTR OF ACTCACACGGCCTCATACAG based on AV121
MO200 Tax-39 LTR OR ACGCAGTTCAGGAGGCAC based on AV122
MO201 Tax-39 LTR IF CTGTTTGAAGAATACACCAACATCC based on AV123
MO202 Tax-39 LTR IR CTCAACCGGCGTGGATGG based on AV124
MO076 p24 OF TCCCTCCTAGCCAGCCTAC
MO079 p24 OR TCTCGCTTCCAGTGAGTTGG
MO077 p24 IF CATCCAAACCCAAGCCCAGA
MO078 p24 IR CTCCAGTGGCCTGCTTTCC
OF, outer forward; OR, outer reverse; IF, inner forward; IR, inner reverse.
Primers MO195-MO202 based on, but not identical to primers described in
Salemi et al. [21].
doi:10.1371/journal.pntd.0001690.t001
Table 2. Characteristics of subjects of whom HTLV-1 LTR and/
or p24 sequences were obtained from Caio´, Guinea-Bissau,
2003–2007.
Characteristic
Total number of subjects of whom sequences were available 72
Number of women (%) 54 (75)
Number of children (aged ,15 years) (%) 8 (11)
Median age at diagnosis in years (IQR) 41 (24–64)
Number of subjects co-infected with HIV (%) 25 (35)
Subjects of whom LTR sequence was available(%) 48 (67)
Subjects of whom p24 sequence was available (%) 36 (50)
Subjects of whom both LTR and p24 sequence were available (%) 12 (17)
IQR, interquartile range.
doi:10.1371/journal.pntd.0001690.t002
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Figure 1. ML tree of 630-bp LTR sequences from 48 Caio infected subjects (Caio sequences in red). Also included are 66 STLV/HTLV-1
reference sequences (in black); Mel5 was used as an outgroup. The names of the countries of origin are denoted in brackets (CAR, Central African
Republic). The phylogenetic tree was inferred under a Tamura-Nei evolutionary model with a gamma model of among-site substitution rate
heterogeneity. Bootstrap values using 1000 replicates of $60 are indicated on the branches. The asterisks indicate significant branch length on ML
testing (* p-value#0.001; ** p-value#0.05). The scale bar represents the number of nucleotide substitutions per site. The scale of the MarB43 is not
on scale because it did not fit in the figure. Sequences identical to Caio4676 are Caio4126, Caio4142, Caio4315, Caio4768, Caio5324, Caio5801,
Caio6460, Caio6936 and Caio7120. Sequence identical to Caio4647 is Caio4650. Sequence identical to Caio4799 is Caio4801. Sequences identical to
Caio5620 are Caio4743, Caio4745 and Caio5883. Sequences identical to Caio5187 are Caio5846, Caio5884 and Caio5931. Sequences identical to
Molecular Epidemiology of HTLV-1 in Guinea-Bissau
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Caio4659; Caio4743 & Caio4745; Caio4671& Caio4702;
Caio4799 & Caio4801). Within each of these 8 family pairs, the
viruses showed 100% identical sequences.
Molecular typing
First, LTR sequences were analyzed to identify the HTLV-1
subtypes present in the village (Table S1). Identical HTLV-1 LTR
sequences were found in known relatives but were also obtained
from 10 unrelated individuals with no known epidemiological links
(not related or known sexual partners) (Figure 1). Stringent control
measures were in place to prevent cross-contamination during
sample handling and PCR, and there was a consistent absence of
product in all negative controls (run with each set of PCR
reactions). In addition there was no clustering of identical
sequences by day of sample preparation. The nonidentical
sequences exhibited 1 to 3% divergence for the LTR.
A phylogenetic tree was constructed with all nonidentical LTR
sequences (Figure 1 - the identical sequences are listed in the figure
legend). With a single exception the Caio sequences (marked in
red) clustered with HTLV-1 subgroup D reference strains isolated
from pregnant women from Bissau (capital of Guinea-Bissau) and
other West and North African individuals.
One virus LTR sequence, Caio4064, was very divergent (6%)
from the major group of Caio subtype 1a isolates. Caio4064
clustered significantly with an STLV-1 sequence obtained from a
wild African green monkey in the Central African Republic [29]
(Tan90) and with HTLV-1 subtype 1g isolated from a Camer-
oonian monkey hunter (2656ND) [7]. The Caio4064 sample was
obtained from a 65-year old woman diagnosed with HTLV-1
(proviral load: 22 copies per 105 cells) and HIV-2 (viral load:
undetectable) infection in 1990. She had not travelled outside of
Guinea-Bissau and had not been bitten by a monkey or hunted
monkeys (information obtained in the 1997 survey). Her husband
was HTLV-1 negative in the most recent survey (2007).
Further evidence for the presence of subtype 1g was obtained by
examining a set of p24 sequences obtained from 36 individuals
(Table S1, Figure 2 - the identical sequences are listed in the figure
legend). Although both LTR and p24 sequences were not
available for all subjects, there was sufficient overlap between
the two sets of sequences to make some important conclusions.
Sixteen individuals with no epidemiological links to each other (not
related and not sexual partners) had identical p24 sequences. A
ML-tree was constructed from the non-identical sequences; 32 of
the Caio p24 sequences formed a single cluster. Consistent with
the LTR phylogeny, Caio4064 p24 clustered significantly with the
Tan90 p24 and an additional Caio sample, Caio65552.
Caio65552 was obtained from a 62 year old man who reported
having hunted monkeys in the Caio area, but had no recollection
of being bitten by a monkey. The subject was diagnosed with
HTLV-1 (proviral load: 2199 per 105 cells) and HIV-2 (viral load:
undetectable) in 1997. He was not married and had no
epidemiological link with the patient providing Caio4064. No
samples were available from the mothers of subjects providing
Caio4064 or Caio65552 to examine vertical transmission.
Discussion
This is the first characterization of the sequence diversity of
HTLV-1 within a single, endemic community in West Africa with
sequences obtained from 72 adults and children. An important
feature of this study is that individuals were screened for HTLV-1
in population surveys and were not selected from a clinical setting,
thus avoiding selection bias towards diseased individuals. Most of
the sequences identified belonged to HTLV-1 Cosmopolitan
subtype 1a subgroup D. However, two subjects were found to be
infected with a divergent strain of HTLV-1 which clustered
significantly with subtype 1g. This is the first time that this novel
subtype has been isolated from individuals in West Africa and
suggests this subtype has spread into the human population outside
of Cameroon, either by human-to-human or interspecies trans-
mission.
Remarkable genetic stability in 1aD sequences was observed
and in particular, 10 identical LTR sequences and 16 identical
p24 sequences were found in people with no identified epidemi-
ological links. These infections differed in time of diagnosis, route
of infection (vertically and horizontally) and the length of the
infection (a few years vs. .14 years). This observation is consistent
with the very low evolutionary rate of HTLV-1 (estimated at
7.066102721.3861025 substitutions per site per year) [9], which
is probably explained by clonal expansion of the virus (rather than
viral replication) [30]. Whether this genetic stability is also
influenced by host factors and whether specific viral variants are
associated with proviral load and/or disease progression are
important questions that remain to be elucidated. With such a
limited degree of viral variation observed across a community
cohort, combined with the low rate of progression to any HTLV-1
associated disease it is difficult to identify such an association. In
Caio, 7.1% of HTLV-1 infected individuals were diagnosed with
HTLV-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) [31], but no data regarding Adult T-cell Leukemia
are available. HTLV-1 infection in a large cohort study from Caio
was found to be associated with increased mortality, especially
among younger people and an increased proviral load was
associated with increased mortality [32].
HTLV-1aD was the predominant variant in our study
population, consistent with other studies from Bissau and Senegal
[33,34]. Recently, this variant was also described in Europe in
patients from West Africa who had emigrated to Portugal [35].
HTLV-1 phylogeny has been examined in a historical context to
trace the origin of the virus and movement of people. While slaves
who were brought to South America came from West Africa
including Guinea-Bissau, surprisingly subgroup D has not been
found among African descendants in South America. Subgroup A
and C are prevalent among African descendants, for example in
Brazil and French Guyana. Subgroup A could have been
introduced into Brazil through slaves that came from Southern
Africa [14,36]. Subgroup C has been found in the Noir Marron, a
distinct population of African origin, who settled in French
Guyana and the majority of whom originated from the Bight of
Benin (present-day Togo, Benin and a part of Nigeria) and Gold
Coast (a part of Ivory Coast and Ghana) [37]. The fact that
subgroup D has not been described in these populations may be
due to subgroup C being older and/or a later introduction of
subgroup D into West Africa (so that the prevalence was low or
absent during the slave trade). It could also be that the number of
slaves, originally from the countries where subgroup D was
prevalent, was (relatively) low. To answer this question, additional
analysis of both host and viral genetic markers is required. More
sampling in West Africa and in groups of African descent in South
America could shed light on this issue.
Caio4634 are Caio4635 and Caio5448. Sequences identical to Caio4758 are: Caio4658, Caio4659 and Caio4757. Sequence identical to Caio4671 is
Caio4702. Sequences identical to 7580 are 7421 and 7661. Only one example of each set of identical sequences was included in the analysis.
doi:10.1371/journal.pntd.0001690.g001
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The finding of two instances of HTLV-1 subtype 1g, Caio4064
and Caio65552, from the Caio community is of great interest for
several reasons. It indicates that this subtype is present beyond
Cameroon and can also be found in a ‘normal’ community
member, i.e. not only in people with close contact to monkeys such
as hunters.
That subtype 1g isolates cluster significantly with Tan90, the
most divergent African STLV-1 strain, gives support to an African
origin of HTLV-1 with the oldest known STLV-1 as the most
recent common ancestor of Caio4064/Caio65552. Although the
Asian MarB43 is the most divergent STLV-1, it does not cluster
with any known HTLV-1 strains and thus may be only distantly
related to STLV subgroups that moved into humans. While most
African STLV and HTLV strains cluster together, mainly by
geographic location, Asian STLV and HTLV strains only cluster
by species, suggesting cross-species transmission has frequently
occurred in Africa and not in Asia [11]. No simian strain has been
described yet which clusters with HTLV-1a, the most widespread
subtype. Whether this is due to relatively infrequent sampling of
non-human primates or due to other factors, remains to be
resolved [38].
The presence of HTLV-1 subtype 1g infection could be the
result of human to human contact (Caio residents do travel
extensively [39]). Alternatively, a zoonotic transmission may also
explain the presence of this subtype. Hunting of monkeys and
butchering for human consumption is commonly practiced [40].
In Caio, captured monkeys are often kept tethered in household
compounds for future consumption and HTLV-1 infection has
been found to be associated with monkey bites among older
persons in the capital Bissau [41]. These social factors, combined
with the low evolutionary rate of HTLV-1 [9] are consistent with
subtype g virus appearing in Caio due to a transmission from a
local monkey. Indeed, the 62 year old Caio man yielding
Caio65552 reported hunting monkeys in the area; however, the
woman from whom the Caio4064 isolate was obtained, reported
that she did not hunt monkeys and was not bitten by one
Figure 2. ML tree of 647-bp p24 sequences from 36 Caio infected subjects (Caio sequences in red). Also included are 15 STLV/HTLV-1
reference sequences (in black); Mel5 was used as an outgroup. The countries of origin are denoted in brackets (CAR, Central African Republic; NA, not
available). The phylogenetic tree was inferred under a Tamura-Nei evolutionary model with a gamma model of among-site substitution rate
heterogeneity. Bootstrap values using 1000 replicates of $60 are indicated on the branches. The asterisks indicate significant branch length on ML
testing (* p-value#0.001; ** p-value#0.05). The scale bar represents the number of nucleotide substitutions per site. Sequences identical to Caio4009
are Caio4072, Caio4106, Caio4112, Caio4211, Caio4315, Caio4328, Caio4358, Caio4383, Caio4417, Caio4418, Caio5801, Caio6473, Caio6590, Caio65396
and Caio65407. Sequence identical to Caio65363 is Caio65571. Sequence identical to Caio4258 is Caio65325. Only one example of each set of
identical sequences was included in the analysis.
doi:10.1371/journal.pntd.0001690.g002
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suggesting that her infection came about by another route.
Iatrogenic spread should also be considered, as both individuals
are older and co-infected with HIV-2 [42,43].
HTLV-1 infection is considered to be largely an infection of
older women [44]. However, 6 young men (16 years of age) were
found to have become infected with HTLV-1 between 1997–2007
in the Caio community [15], which led us to consider transmission
during traditional local, non-sterile, male circumcision ceremonies.
These take place every ten years in a sacred part of the Caio forest.
This initiation ritual is exclusively for men and lasts three months.
Three men included in the current analysis were known to have
participated in the same circumcision ceremony. However, the
LTR sequences from the viruses found in these 3 men (yielding
Caio5187 & Caio5801 & Caio7580) were not identical and no
more closely related to each other than to sequences from the
wider Caio population. (i.e. they did not cluster separately from
the larger subgroup D cluster (Figure 1)). Both of these features
would have been expected if the virus in these three subjects had
been transmitted by infected blood in such a ceremony [45,46].
Thus, although a traditional circumcision ceremony has the
potential to spread blood borne viruses, the phylogenetic data
clearly do not support the idea that this ceremony was the source
of HTLV-1 infection of these young men.
Epidemiological surveillance and further sequencing are
recommended to identify (novel) HTLV-1 subtypes [47,48] and
to investigate the spread of subtype 1g. It would be of particular
interest to investigate to what extent new introductions of HTLV
subtypes (and potentially other retroviruses) [7,49,50] occur and
whether non-sexual, non-vertical transmission takes place in this
community. Further testing of indeterminate HTLV-1/2 ELISA
samples found in this community [15] could indicate for example
whether HTLV-2 is also present in Caio [51]. This may lead to a
better understanding of the spread of other zoonotic events, of
which the HIV pandemic is a major example [40], and can have
important public health implications.
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